ARCHIVES

Authorizes $2.7 Billion For NCI, 7% Prevention

This article is from The Cancer Letter archive.

Vol. 19 No. 22 | May 28, 1993

Download PDF Visit The Full Archive

Related Articles

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980

FDA Approves Rituxan For CLL

February 19, 2010

In Brief: Daniel Nixon Of Emory to Head Prevention Program; Henderson To Get Rosenthal Award

January 30, 1987

Cancer Biomarker Research “Piecemeal and Unorganized,” IOM Report Finds.

April 6, 2007

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999

NHIS Cancer Control Supplement To Survey 52,000

October 4, 1985